Photo taken from ghealth121.com
Jul 25, 2024, 01:39
An update on the development of HER2-targeted therapies
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:
“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”
HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology
Autors: Jeesun Yoon and Do-Youn Oh
Source: Elisabetta Bonzano/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 10:30
Apr 21, 2025, 10:27
Apr 21, 2025, 10:25
Apr 21, 2025, 10:22
Apr 21, 2025, 10:17